How much funding has Biocartesian raised?

Biocartesian has raised $500K in total funding, most recently a Seed round.

Who are Biocartesian's investors?

Biocartesian's investors include Y Combinator Continuity Fund.

When was Biocartesian founded?

Biocartesian was founded in 2023.

Where is Biocartesian headquartered?

Biocartesian is headquartered in San Francisco, California, United States.

What industry is Biocartesian in?

Biocartesian operates in Biotech, Deep Tech, Diagnostics, Drug Discovery, Healthcare.

How many employees does Biocartesian have?

Biocartesian has 1-10 employees.

Biocartesian

Converting biology into digital molecular maps

San Francisco, United States · Founded 2023 · $500K raised

YC S24

Headquarters: San Francisco, California
Employees: 1–10
Founded: 2023
Website: biocartesian.com

Total Funding: $500K
Last Round: $500K SeedJan 2024
Rounds: 1

About

Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.

Summary

Biocartesian is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $500K in total across 1 round, most recently a $500K Seed round in Jan 2024. Investors include Y Combinator Continuity Fund.